Your browser doesn't support javascript.
loading
Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study.
Combe, Bernard G; Tanaka, Yoshiya; Buch, Maya H; Nash, Peter; Burmester, Gerd R; Kivitz, Alan J; Bartok, Beatrix; Pechonkina, Alena; Xia, Katrina; Emoto, Kahaku; Kano, Shungo; Hendrikx, Thijs K; Landewé, Robert B M; Aletaha, Daniel.
Afiliação
  • Combe BG; Montpellier University, Montpellier, France. b-combe@chu-montpellier.fr.
  • Tanaka Y; Rheumatology Department, Lapeyronie Hospital, Montpellier University, 34295, Montpellier Cedex 5, France. b-combe@chu-montpellier.fr.
  • Buch MH; The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
  • Nash P; NIHR Manchester Biomedical Research Centre, University of Manchester, Manchester, UK.
  • Burmester GR; Griffith University of Queensland, Brisbane, Australia.
  • Kivitz AJ; Charité University Hospital Berlin, Berlin, Germany.
  • Bartok B; Altoona Center for Clinical Research, Duncansville, PA, USA.
  • Pechonkina A; Gilead Sciences, Inc., Foster City, CA, USA.
  • Xia K; Gilead Sciences, Inc., Foster City, CA, USA.
  • Emoto K; Gilead Sciences, Inc., Foster City, CA, USA.
  • Kano S; Gilead Sciences K.K., Tokyo, Japan.
  • Hendrikx TK; Gilead Sciences K.K., Tokyo, Japan.
  • Landewé RBM; Galapagos NV, Mechelen, Belgium.
  • Aletaha D; Amsterdam Rheumatology and Clinical Immunology Center (amC) and Zuyderland MC, Heerlen, The Netherlands.
Rheumatol Ther ; 10(1): 53-70, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36209441

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Rheumatol Ther Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Rheumatol Ther Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França